AI and Digital Biomarkers: Pioneering Early Detection in Schizophrenia and Their Impact on Industry Expansion – 2024 Breakthroughs
Artificial Intelligence (AI) and digital biomarkers are emerging as game-changers in schizophrenia diagnosis, enabling earlier intervention and reducing the disease’s long-term impact. Traditional diagnosis relies on clinical interviews, which can miss early symptoms or misclassify them as other conditions (e.g., anxiety). Digital tools, such as AI-driven speech analysis and neuroimaging...
0 Comments 0 Shares 33 Views 0 Reviews